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The article is devoted to the actual problem today - the study of the relationship immunodependent mechanisms of gene deletion 
glutathione-S-transferase in a brilliant development of endometriosis. Gene network of this disease is rather complicated and 
diverse. It includes various genes metabolism (detoxi cation), genes that are responsible for immune status of genes and cell-
cell interactions. Polymorphism of genes of detoxi cation often in uences the functional activity of the molecular structure of 
DNA. In recent years in world literature there is more data to the pathological processes in the human body is due to immune 
regulation and characterized by a certain imbalance of pro- or anti-in ammatory cytokines, which contribute to the occurrence 
of endometriosis and can in uence the effectiveness of treatment.
Стаття присвячена актуальній проблемі сьогодення – вивченню  взаємозв’язку імунозалежних механізмів із делецією 
генів глутатіон-S-трансферази у розвитку генітального ендометріозу. Генна мережа цього захворювання є досить склад-
ною та різноманітною. Вона включає різні гени метаболізму (детоксикації), гени, що відповідальні за імунний статус, та 
гени міжклітинних взаємодій. Поліморфізм генів детоксикації дуже часто суттєво впливає на функціональну активність 
молекулярної структури ДНК. Протягом  останніх років у світовій літературі з’являється все більше даних, що перебіг 
патологічних процесів в організмі людини відбувається за рахунок імунологічної регуляції і характеризується пев-
ним дисбалансом про- чи протизапальних цитокінів, які сприяють виникненню ендометріозу та можуть впливати на 
ефективність його лікування. 
Staging of problem and analyses of recent 
researches and publication. During the last several 
years genital endometriosis had the leading role in the 
structure of gynecological diseases, with occurrence 
ranging between 12 % and 50 % in women of repro-
ductive age. While there are numerous theories explai-
ning the etiology of the disease, none of the fully explain 
the nature of the pathology [1, 2]. Current opinion exa-
mines this disorder as pathological process with a chro-
nic, recurring pattern. Endometriosis develops in the 
woman's body due to a disbalance between the immune, 
endocrine and molecular-genetic processes [3] .
It is known that the genesis of genital endometri-
osis (GE) is related to genes responsible for metabo-
lism, characterized by a highly variable DNA struc-
ture. Enzymes of the Guthionine S-Transferase (GST) 
family play a key role in providing cell resistance to 
lipid peroxydation by free radicals, alkilizing of pro-
teins and forming resistance to medications prevent-
ing DNA damage [4, 5]. The course of all pathologi-
cal processes in the body happen due to the immune 
system's regulation and are characterized by certain 
interactions of anti-in ammatory cytokines. From our 
literature analysis of the genetic component of endo-
metriosis development, one may assume that a break-
down of the humeral response's intercellular reactions 
is a possible cause of the pathology in a single la yer 
of the uterus. Currently, the role of the humeral res-
ponse in regulating immune reactions is well studied 
[6, 7, 8]. The key endogenous immunoregulators that 
play an active role in the proliferating processes of the 
uterus and especially active during endometriosis are 
interleukin 6 (IL-6), interleukin 8 (IL-8), and tumor 
necrosis factor alpha (TNFα). Therefore, the goal of 
our inquiry was to determine the role of polymorpho-
sis of the GSTM1, GSTT1 genes and immune-depen-
dent mechanisms in the development of GE.                   
Materials and methods. The clinical portion was 
carried out at the Ternopil Perinatal Center “Mother 
and Child.” Laboratory diagnostics in the interdepart-
mental scienti c-clinical laboratory of SHEI “Terno-
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pil State Medical University  by I. Ya. Horbachevsky 
of MPH of Ukraine”. 40 female patients were admit-
ted with GE, aged from 27 to 45. The control group 
consisted of 20 women determined to be without GE 
after inspection, as well as without any signs of ova-
ry or menstrual dysfunction. All patients granted in-
formed consent for the collection of venous blood for 
research purposes. For genetic testing 3–5 ml of ve-
nous blood from the v. cubitalis was extracted un-
der standard conditions in the morning, before food 
intake and stored in a special vaccum system – 3 % 
EDTA.
Frequencies of GSTM1 and GSTT1 polymorph 
varieties were obtained with the help of a polymerase 
chain reaction. Extraction of DNA from peripher-
al blood was done with the the “АмпліСенс” (Amp-
Table 1. Distribution of GSTM1 and GSTT1 genotypes in the observed and control group
Gene Genotype
Observed group Control group
n=40 n=20
GSTM1 0/0 22 (55 %) 9 (45 %)
+/+ 18 (45 %) 11 (55 %)
GSTT1 0/0 19 (47.5 %) 5 (25 %)
+/+ 21 (52.5 %) 15 (75 %)
Table 2. Immune system indicators in the observed, control group and clinical norm
Indicator Observed group, n=40 Control group, n=20 Normal Levels
IL=6 (pg/ml) 14.5 7.5 <10 (pg/ml)
IL=8 (pg/ml) 148, 0 21.5 <30 (pg/ml)
TNFα (pg/ml) 5.5, 0 3.5 <5 (pg/ml)
lisense) testsystem according to the instructions pro-
vided with the product. Identifying insertion – dele-
tion polymorphism in the GSTM1 and GSTT1 genes 
(Glutathione - S-transferase class T1 and M1) was car-
ried out with the polymerase – chain reaction, “NEO-
GEN”, Kyiv. Homozygous and heterozygous positive 
GSTM1 and GSTT1 gene alleles were determined on 
an electropherogram by the presence of a genetic ma-
terial on the 218 and 460 mark respectively. Absence 
of those markers indicated homozygous deletion of 
the individual’s genes. (Results of genotype distribu-
tion  are represented in Table 1).
Serum interleukin levels were determined through 
Enzymed linked immunosorbant assay (ELISA) 
test using an ELISA test system. (Immune system 
indicators are represented in Table 2).
Researsh results and their discussions. The 
analysis of polimor sm variants of the GSTM1 gene 
did not yield a statistically signi cant difference 
between the mutation frequencies among the group 
diagnosed with endometriosis as compared to the 
control group (55 % and 45 % respectively). 
The occurrence of a homozygous GSTT1 zero 
allele turned out to be signi cantly higher in women 
diagnosed  with endometriosis as opposed to the con t-
rol group. We analyzed the genotype combinations of 
two guluthionine S-transferase genes in the observed 
and control groups. Worth mentioning, deletions both 
in the GSTM1 and GSTT1 genes occurred considerably 
more often in the observed group compared to the 
control group.
From our analysis of the immunological indica-
tors in both patient groups, we observed that IL-6 
levels were approximately twice as high in patients 
with GE than in asymptomatic patients. This data 
supports the localization of IL-6 function; the concen-
trations observed in the treatment group indicate an 
in ammatory and immune response. IL-8 levels were 
observed to be almost seven times higher in patients with 
GE as opposed to the healthy group. These results may 
suggest the importance of the role of the non-speci c 
immune system cells during GE in ammation. 
The group of patients with adenomyosis had 
TNFα levels aprox. 1.5 higher than the control group, 
which is a positive sign of in ammation. Since tumor 
necrosis factors ful ll multiple important functions in 
the body and have a pleiotropic effect on other genes, 
it follows that TNFα has a substantial effect on the 
differentiation, proliferation and activation of cells 
involved in the in ammation process. 
Conclusions. 1. The clinical inquiry establishes 
a positive correlation between endometriosis and 
the null genotypes of the two 2nd stage detoxi cation 
genes (GSTM1, GSTT1) and this will hopefully 
have a signi cant impact on the development of new 
methods to treat and prevent the disease given the 
individual properties of the genome.
2. Women with adenomiosis  had an observed 
elevation of IL-6 and  TNFα blood serum levels that 
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suggests an adequate cytokinetic regulation of the 
immune response during in ammation. Since the 
primary function of IL-8 is to encourage neutrophil 
migration to the site of in ammation, a high 
concentration suggests an activated innate immune 
response.
Perspectives of further studies. Therefore, fur-
ther research into the role and function of factors 
regulating the immune response and deletions of 
gluthionine S-transferase is a potential route for 
determining possible markers for genital endometrio-
sis without the use of invasive procedures. 
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